Skip to main content
Frontiers in Endocrinology logoLink to Frontiers in Endocrinology
. 2015 Jun 9;6:98. doi: 10.3389/fendo.2015.00098

Corrigendum: “Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac”

Paul J Davis 1,2,*, Gennadi V Glinsky 3, Hung-Yun Lin 4, John T Leith 5, Aleck Hercbergs 6, Heng-Yuan Tang 2, Osnat Ashur-Fabian 7,8, Sandra Incerpi 9, Shaker A Mousa 2
PMCID: PMC4460813  PMID: 26106368

In Table 2, the section designated “Disabling of cell survival pathway gene expression,” line 5 incorrectly states “…pro-apoptotic miR-21”; the correct statement is “…pro-apoptotic miR-15A.” The issue is correctly discussed in the body of the published text, p. 2, right column, paragraph 4.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.


Articles from Frontiers in Endocrinology are provided here courtesy of Frontiers Media SA

RESOURCES